Clinical Trial Update: Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (FORAT) evaluating thrombolysis with recombinant non-immunogenic staphylokinase versus surgery for acute limb ischemia; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb Ischemia

Drugs mentioned

• Staphylokinase, recombinant (non-immunogenic) (staphylokinase, recombinant, non-immunogenic)

Snippet

Sponsor: Supergene, LLC | Conditions: Acute Limb Ischemia | Phase 3 | Status: RECRUITING